Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
ICICI Prudential Bharat Consumption Fund Series 1 Direct Growth
+17.47%
3Y annualised
+0.50% 1D
NAV: 01 Nov '21
₹16.04
Min. for SIP
Not Supported
Fund size (AUM)
₹1,429.96 Cr
Expense ratio
1.11%
Rating
--
Holdings (30)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Repo | Unspecified | Repo | 54.92% |
| Asian Paints Ltd | Materials | Equity | 7.18% |
| Britannia Industries Ltd | Consumer Staples | Equity | 6.25% |
| Alkem Laboratories Ltd | Healthcare | Equity | 2.77% |
| Nestle India Ltd | Consumer Staples | Equity | 2.57% |
| Gland Pharma Ltd | Healthcare | Equity | 2.56% |
| Marico Ltd | Consumer Staples | Equity | 2.56% |
| Fortis Healthcare Ltd | Healthcare | Equity | 2.42% |
| Others EMM | Unspecified | Equity Margin Money | 2.16% |
| Divi's Laboratories Ltd | Healthcare | Equity | 2.15% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 2.12% |
| Aditya Birla Fashion and Retail Ltd | Consumer Discretionary | Equity | 2.00% |
| Titan Company Ltd | Consumer Discretionary | Equity | 1.90% |
| Hindustan Unilever Ltd | Consumer Staples | Equity | 1.55% |
| Samvardhana Motherson International Ltd | Consumer Discretionary | Equity | 1.49% |
| Tata Motors DVR | Consumer Discretionary | Differential Voting Rights | 1.35% |
| Lupin Ltd | Healthcare | Equity | 1.34% |
| Maruti Suzuki India Ltd | Consumer Discretionary | Equity | 0.75% |
| Biocon Ltd | Healthcare | Equity | 0.67% |
| Ashok Leyland Ltd | Industrials | Equity | 0.42% |
| Ipca Laboratories Ltd | Healthcare | Equity | 0.41% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 0.35% |
| Jubilant FoodWorks Ltd | Consumer Discretionary | Equity | 0.31% |
| INOX Leisure Ltd | Consumer Discretionary | Equity | 0.26% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 0.19% |
| Bharti Airtel Ltd | Technology | Equity | 0.09% |
| Cipla Ltd | Healthcare | Equity | 0.04% |
| Ajanta Pharma Ltd | Healthcare | Equity | 0.02% |
| Ambuja Cements Ltd | Materials | Equity | -- |
| Net Payables | Unspecified | Net Payables | -0.79% |
See All
Minimum investments
Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported
Returns and rankings
Annualised returns
Absolute returns
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +17.1% | +53.9% | +17.5% | +14.2% |
| Category average (Equity Thematic) | +16.3% | +45.6% | +13.6% | -- |
| Rank (Equity Thematic) | -- | 4 | 4 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
About ICICI Prudential Bharat Consumption Fund Series 1 Direct Growth
ICICI Prudential Bharat Consumption Fund Series 1 Direct Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 12 Oct 1993. The fund currently has an Asset Under Management(AUM) of ₹11,18,142 Cr and the Latest NAV as of 01 Nov 2021 is ₹16.04.
The ICICI Prudential Bharat Consumption Fund Series 1 Direct Growth is rated Very High risk.
;
Investment Objective
The Scheme seeks to provide capital appreciation by investing predominantly in equity and equity related instruments of sectors that could benefit from growth in consumption and related activities.
Fund benchmarkNIFTY India Consumption Total Return Index
Fund house
Rank (total assets)#3 in India
Total AUM₹11,18,141.85 Cr
Date of Incorporation12 Oct 1993
Launch Date12 Oct 1993
AddressOne BKC , A Wing ,13th Floor, Bandra Kurla Complex, Mumbai 400051
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,